top of page

Clinical Trial
For information on the clinical trial and how to enroll, please click here. Alternatively, submit your name and contact information here.
Recent news on the trial:
"Bionic Sight's BS01 Gene Therapy Receives RMAT Designation from the FDA"
GlobeNewswire, February 18, 2025
"Restoring Sight is Possible Now With Optogenetics": Bionic Sight's interim clinical trial results
Washington Post, April 23, 2024
Foundation Fighting Blindness, April 21, 2023
Positive Interim Results in Bionic Sight's Optogenetic Gene Therapy Trial
Presentation at conference entitled, "Gene Therapy for Ophthalmic Disorders", Sept, 2021
GlobeNewswire, March 30, 2021
For other related news, click here.
bottom of page